These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Authors' reply to: Letter from Arguedas et al. Kim MJ; Kim JH; Chun BC; Yang KS Vaccine; 2019 Dec; 37(52):7532-7533. PubMed ID: 31783979 [No Abstract] [Full Text] [Related]
23. Authors' reply to the letter to the editor from Castagna et al. Maki Y; Sano T; Kimizuka Y; Kawana A Geriatr Gerontol Int; 2021 Apr; 21(4):372. PubMed ID: 33576124 [No Abstract] [Full Text] [Related]
24. The authors' reply to the letter from Kerkhof Prior DL; Stevens SR; Al-Khalidi HR; Holly TA; Berman DS; Heart; 2018 Jan; 104(2):1. PubMed ID: 29298847 [No Abstract] [Full Text] [Related]
25. Authors' reply concerning the letter by Ensminger et al. Weis M; Steinbeck G; Reichart B; Hübner T; Nickel T; Massberg S; Schramm R; Hagl C; Kiwi A Clin Res Cardiol; 2015 Nov; 104(11):1000-2. PubMed ID: 26349784 [No Abstract] [Full Text] [Related]
26. Letter: evaluation and proposed reclassification of HCC prediction model of Tahata et al. in chronic hepatitis C genotype 4 patient. Authors' reply. Tahata Y; Sakamori R; Yamada R; Kodama T; Hikita H; Hagiwara H; Imai Y; Hiramatsu N; Tamura S; Yamamoto K; Oshita M; Ohkawa K; Hijioka T; Fukui H; Ito T; Doi Y; Yamada Y; Yakushijin T; Yoshida Y; Tatsumi T; Takehara T; Aliment Pharmacol Ther; 2022 Jan; 55(2):258-259. PubMed ID: 34970764 [No Abstract] [Full Text] [Related]
27. Authors' reply to the letter to the editor by Wills et al. Tu YK; Tilling K; Sterne JA; Gilthorpe MS Int J Epidemiol; 2014 Oct; 43(5):1664-5. PubMed ID: 24585731 [No Abstract] [Full Text] [Related]
28. Authors' reply to the Letter to the Editor of J. Padulo et al. concerning "Video raster stereography back shape reconstruction: a reliability study for sagittal, frontal, and transversal plane parameters" by Schroeder J, Reer R, Braumann KM (2015), Eur Spine J; 24(2):262-269. DOI: 10.1007/s00586-014-3664-5. Schroeder J Eur Spine J; 2015 Sep; 24(9):2102-3. PubMed ID: 25801743 [No Abstract] [Full Text] [Related]
29. Authors' reply to letters from Egilman et al and Oliver et al. Peto J; Gilham C; Rake C; Darnton A; Hodgson J; Burdett G Occup Environ Med; 2016 Oct; 73(10):710-1. PubMed ID: 27466613 [No Abstract] [Full Text] [Related]
30. Authors' reply to Jayaraj et al. 's Letter to the Editor re: MIR196A2 rs11614913 contributes to susceptibility to colorectal cancer in Iranian population: A multi-center case-control study and meta-analysis. Haerian MS; Haerian BS; Molanaei S; Kosari F; Sabeti S; Bidari-Zerehpoosh F; Abdolali E Gene; 2021 Oct; 801():145849. PubMed ID: 34274466 [No Abstract] [Full Text] [Related]
31. Authors' reply to letter to the editor concerning "Li P, lv Y, Zhou F, et al. Medial wall fragment involving large posterior cortex in pertrochanteric femur fractures: a notable preoperative risk factor for implant failure. injury. 2020". Li P; Lv Y; Zhou F Injury; 2020 Aug; 51(8):1931-1933. PubMed ID: 32487329 [No Abstract] [Full Text] [Related]
32. Letter: faecal calprotectin and lactoferrin - accurate biomarkers in post-operative Crohn's disease - authors' reply. Letter: biologic therapies are effective for prevention of post-operative Crohn's disease recurrence - authors' reply. Jones GR; Kennedy NA; Lees CW; Arnott ID; Satsangi J Aliment Pharmacol Ther; 2014 Aug; 40(3):323. PubMed ID: 25040750 [No Abstract] [Full Text] [Related]
33. Authors' Reply to: VanderWeele et al., Chiolero, and Schooling et al. Broadbent A; Vandenbroucke J; Pearce N Int J Epidemiol; 2016 Dec; 45(6):2203-2205. PubMed ID: 27524813 [No Abstract] [Full Text] [Related]
34. Authors' response to the letter from Kalleian Eserian et al. van Riet-Nales DA; Doeve ME; Nicia AE; Teerenstra S; Notenboom K; Hekster YA; van den Bemt BJ Int J Pharm; 2015 Jan; 478(2):682-3. PubMed ID: 25445969 [TBL] [Abstract][Full Text] [Related]
35. Authors' response to comments from Nachman KE et al. O'Connor AM; Auvermann BW; Dzikamunhenga RS; Glanville JM; Higgins JPT; Kirychuk SP; Sargeant JM; Totton SC; Wood H; Von Essen SG Syst Rev; 2017 Oct; 6(1):210. PubMed ID: 29061188 [TBL] [Abstract][Full Text] [Related]
36. Survival in pulmonary fibrosis combined with emphysema: likely defined by characteristics of specific patient subpopulations. Todd NW; Atamas SP Fibrogenesis Tissue Repair; 2011 Jul; 4():17. PubMed ID: 21787427 [TBL] [Abstract][Full Text] [Related]
37. Authors' reply to the Letter to the Editor of J. Bakhsheshian et al. concerning "Intrawound vancomycin to prevent infections after spine surgery: a systematic review and meta-analysis" by Evaniew N, Khan M, Drew B, Peterson D, Bhandari M, Ghert M (2014) Eur Spine J; DOI 10.1007/s00586-014-3357-0. Evaniew N; Ghert M Eur Spine J; 2014 Sep; 23(9):2016. PubMed ID: 24981673 [No Abstract] [Full Text] [Related]
38. Letter to the Editor: Authors' Response to Pitiphat et al. Ioannidou E; Malekzadeh T; Dongari-Bagtzoglou A J Periodontol; 2007 Jul; 78(7):1186-1187. PubMed ID: 29539157 [No Abstract] [Full Text] [Related]
39. Reply to the letter to the editor: [Letter by Yue J, et al. regarding article 'The relationship between atherogenic index of plasma and noreflow in patients with acute ST segment elevation myocardial infarction who underwent primary percutaneous coronary intervention']. Süleymanoğlu M; Rencüzoğulları İ; Karabağ Y; Çağdaş M; Yesin M; Gümüşdağ A; Çap M; Gök M; Yıldız İ Int J Cardiovasc Imaging; 2021 Jan; 37(1):3-4. PubMed ID: 33103223 [TBL] [Abstract][Full Text] [Related]
40. Integrating new evidence about an old drug: authors' reply to Franco et al. and Bell et al. Spruyt O; Le BH; Philip J J Pain Symptom Manage; 2014 Apr; 47(4):e4-5. PubMed ID: 24679556 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]